Why is "Mounjaro" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-07-09 07:11:17
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Mounjaro entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-07-09 and was most recently seen on 2026-07-09.
Wikipedia Overview
Tirzepatide is a gastric inhibitory polypeptide (GIP) analog and a GLP-1 receptor agonist. It is used as an antidiabetic medication to treat type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections. It is sold in several countries under the brand name Mounjaro for diabetes treatment. In the United States it is sold under the brand name Zepbound for weight loss and treatment of obstructive sleep apnea.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
The right way to stop taking Ozempic, Wegovy, or Mounjaro, according to doctors - Yahoo Creators
-
FDA receives applications for generic Mounjaro, Zepbound - NewsNation
-
‘A new consumer’: how weight-loss drugs are shaking up clothes shopping - The Guardian
-
Mounjaro, Zepbound: Generic GLP-1 Drugs May Soon Be Available - Healthline
-
How weight-loss drugs are changing what people buy - Korea JoongAng Daily
-
Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review - Cureus
-
Switching From Ozempic To Mounjaro: What To Discuss With Your Health Care Provider - Forbes
-
Weight-loss pills: can orforglipron preserve weight loss after Mounjaro? - British Heart Foundation
-
From mouthwash to hair dye: How weight-loss jabs are changing shopping habits - BBC
-
Three burglars jailed after stealing nearly £1m worth of Mounjaro - The Crown Prosecution Service
-
Lilly to present new data on Foundayo, Mounjaro and retatrutide at the American Diabetes Association's 86th Scientific Sessions, building toward a new era of choice in diabetes and obesity care - PR Newswire
-
Wegovy and Mounjaro obesity drugs ‘do not improve quality of life’ - thenationalnews.com
-
Here's How Much Eli Lilly's Weight-Loss Drugs Are Worth to Investors - AOL.com
-
Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery - UCHealth
-
GLP-1s Like Ozempic, Mounjaro Linked to Reduced Stroke, Heart Risks - Healthline
-
Compounded Tirzepatide vs. Mounjaro: What’s The Difference? - Forbes
-
Health Canada approves Mounjaro® (tirzepatide) for use in children 10 years and older living with type 2 diabetes - Yahoo Finance
-
Acute Small Bowel Obstruction Induced by Tirzepatide (Mounjaro) - Cureus
-
Tirzepatide Costs, Insurance Coverage & Savings Tips - Forbes
-
Why do Ozempic and Mounjaro work for some people but not others? - The Indian Express
-
I lost almost three stone on Mounjaro – but I fear for vulnerable women - The i Paper
-
Mounjaro burglars caught stealing £1m of weight loss drug from warehouse - Yahoo
-
Mounjaro approved for use in children in UK in ‘significant advance in paediatric care’ - The Pharmaceutical Journal
-
NEWSLETTER: Lilly's Mounjaro tops other GLP-1s for some type 2 diabetes patients - Reuters
-
Burglars jailed for theft of Mounjaro worth £1m in St Albans - BBC
-
Study finds most weight loss drugs including Wegovy and Mounjaro ‘do not improve quality of life’ - The Independent
-
Lilly reports fourth-quarter 2025 financial results and provides 2026 guidance | Eli Lilly and Company - Eli Lilly and Company
-
Benefits of Starting Mounjaro and Ozempic Early - Making Sense of Diabetes
-
Mounjaro burglars caught stealing £1m of weight loss drug from warehouse - The Independent
-
GLP-1 Drugs: Ozempic Preserves Muscle Mass Better Than Mounjaro - Healthline
-
An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 - Eli Lilly and Company
-
Lilly is now the top pharma company by revenue as Mounjaro (+99%) and Zepbound (+175%) combine for $36.5B in FY2025 - drugdiscoverytrends.com
-
Mounjaro ingredient cuts alcohol intake: Research - The Hill
-
Burglars jailed after stealing £1m worth of Mounjaro weight-loss drug from warehouse - The Independent
-
Drugmaker Aspen targets Mounjaro approval in sub-Saharan Africa this year - Reuters
-
India seizes suspected fake Mounjaro pens, says raw materials sourced from Alibaba - Reuters
-
Study finds most weight loss drugs including Wegovy and Mounjaro ‘do not improve quality of life’ - AOL.com
-
India's 'Mounjaro brides': weight-loss injections become part of pre-wedding preparation - Reuters
-
Mounjaro maker wants NHS drug price rises in return for more investment in UK - The Guardian
-
Diabetes Drug Mounjaro Misused for Weight Loss Despite Risk of Side Effects - The Japan News
-
Weight loss drugs and cancer: what we know so far - Cancer Research UK - Cancer News
-
South Africa escalates Ozempic crackdown as doctors risk losing licences over copycat weight-loss drugs - Business Insider Africa
-
South Koreans Turn to 'India-jaro' for Cheaper Obesity Treatments - 조선일보
-
Mounjaro Costs, Insurance Coverage & Savings Tips - Forbes
-
Woman says faulty Mounjaro pens left her facing thousands in replacement costs before News 2 investigation - wfmynews2.com
-
Mounjaro, Zepbound Lowers Risk of Cardiovascular Death by 62% - Healthline
-
Korea warns against cosmetic misuse of Wegovy and Mounjaro after mixed results - CHOSUNBIZ - Chosunbiz
-
How Will Mounjaro and Zepbound Sales Aid LLY's Upcoming Q1 Results? - Yahoo Finance
-
If A GLP-1 Medication Has Changed Your Life For The Better, We Want To Hear About It - BuzzFeed
-
Millions of older Americans soon could get popular weight loss drugs for $50 a month, far less than today's prices - UCHealth
-
Can GLP-1 Drugs Like Ozempic Really Change Your Sense of Smell and Taste? - Healthline
-
How To Get Mounjaro: Eligibility Criteria And Where To Buy - Forbes
-
Lilly’s Mounjaro Overtakes ‘King Keytruda’ as World’s Top-Selling Drug - Bloomberg.com
-
How to Keep Mounjaro Safe When You Travel - Healthline
-
UK approves Wegovy pill as studies compare Mounjaro - MSN
-
Lilly Korea to launch higher-dose Mounjaro pens on June 10 - koreabiomed.com
-
Eli Lilly Earnings: Mounjaro/Zepbound's Massive Volume Growth More Than Counters Price Pressure - Morningstar
-
Novo Nordisk Real-World Data Supports Ozempic Against LLY's Mounjaro - Yahoo Finance
-
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans - Eli Lilly and Company
-
UK spurs prescribing of obesity jab Mounjaro with GP bonus - pharmaphorum
-
Pharma Roundup: Mounjaro Shows Advantages in Type 2 Diabetes, Immune System Linked to Long Covid Symptoms - Pharmaceutical Executive
-
Mounjaro vs. Ozempic: What’s The Difference? - Forbes
-
Watch as burglars caught stealing £1m of Mounjaro weight loss drug - The Independent
-
Japan Grapples With Off-Label Mounjaro Trade For Weight Loss - insights.citeline.com
-
Obesity Deep Dive: The Unparalleled Launch Success of Mounjaro and Zepbound - IQVIA
-
France to partially reimburse weight-loss drugs for obesity patients - Le Monde.fr
-
Mounjaro stolen from St Albans pharmaceutical company - BBC
-
What happens when you stop taking Mounjaro? - British Heart Foundation
-
Is there anything GLP-1 agonist drugs cannot do? - dw.com
-
Rosie O’Donnell says she’s lost nearly 60 lbs. with Mounjaro - New York Daily News
-
Eli Lilly CEO David Ricks on Q1 results, Zepbound-Mounjaro sales growth and launch of Foundayo pill - CNBC
-
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk - ScienceDaily
-
Is Mounjaro the New Ozempic? Experts Reveal What You Need to Know Before Trying It - NCHStats
-
'I nearly died after buying skinny jab from friend of friend' - BBC
-
What Is Mounjaro? Why India's Weight-Loss Injection Is Trending Among Brides Amid Fake Drug Cases - Brut
-
Two deaths reported to drug watchdog over potential link to weight-loss jabs - BBC
-
‘Thinness equals beauty’: Mounjaro misuse among women sparks health debate in Japan - The Japan Times
-
Bill could expand Medicaid access to Ozempic, Wegovy and Mounjaro in Louisiana - fox8live.com
-
Three men jailed after weight loss drugs stolen in St Albans - Hertfordshire Constabulary
-
Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125% - Yahoo Finance
-
People taking GLP-1 weight loss drugs like Ozempic started moving less - ScienceDaily
-
Does Mounjaro cause depression? Research, causes, and what to do - Medical News Today
-
India's 'Mounjaro brides': weight-loss injections become part of pre-wedding preparation - Japan Wire by Kyodo News
-
Men jailed over £1m Mounjaro and weight-loss drug theft - Discover SWNS
-
Scientists Uncover New Metabolic Effects Beyond Weight Loss of Mounjaro - SciTechDaily
-
Almost half of weight-loss drug users modify doses, finds survey - The Pharmaceutical Journal
-
Ozempic, Mounjaro: 6 ‘Hidden’ Side Effects of GLP-1 Weight Loss Drugs - Healthline
-
Ireland faces pressure to fund Mounjaro as patients bear €600-a-month cost - euractiv.com
-
Nasty side effects of weight loss drugs no one talks about - The Nightly
-
Record Numbers of Americans Are on GLP-1 Drugs. That's Great News for This Stock. - The Globe and Mail
-
Eli Lilly Profit Rises as Weight-Loss Drug Demand Surges - WSJ
-
GLP-1s Are Busting Employer Budgets. Some Are Getting Creative to Lower Costs. - Tradeoffs
-
Eli Lilly Q1 2026 earnings: Mounjaro, Zepbound drive strong results - qz.com
-
Tirzepatide may only temporarily suppress brain activity involved in ‘food noise’ - Penn Medicine
-
Aspen wins approval to market Lilly's Mounjaro for weight loss in South Africa - Reuters
-
How Will Mounjaro and Zepbound Sales Aid LLY's Upcoming Q4 Results? - Yahoo Finance
-
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All - Yahoo Finance
-
Weight-Loss Injections Bring Hope, Hidden Risks - 조선일보
-
Eli Lilly’s Mounjaro Becomes World’s Top-Selling Drug - The Business of Fashion
-
Reduced alcohol consumption with Mounjaro’s active substance | University of Gothenburg - Göteborgs universitet
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.